SurGenTec was granted FDA 510(k) clearance to market TiLink Navigation Instruments for use with the TiLink SI Joint Fusion System in sacroiliac joint procedures. The system is engineered for compatibility with Medtronic’s StealthStation navigation platform, supporting enhanced precision during minimally invasive SI joint fusion.
The TiLink implant features proprietary Nanotex nano-surface technology and a compression-based design intended to support bone integration and joint stabilization. Pre-clinical ovine studies have demonstrated that Nanotex surface technology promotes both bone on-growth and in-growth at the implant interface, supporting enhanced stability and fusion potential.
SurGenTec was granted FDA 510(k) clearance to market TiLink Navigation Instruments for use with the TiLink SI Joint Fusion System in sacroiliac joint procedures. The system is engineered for compatibility with Medtronic’s StealthStation navigation platform, supporting enhanced precision during minimally invasive SI joint fusion.
The TiLink...
SurGenTec was granted FDA 510(k) clearance to market TiLink Navigation Instruments for use with the TiLink SI Joint Fusion System in sacroiliac joint procedures. The system is engineered for compatibility with Medtronic’s StealthStation navigation platform, supporting enhanced precision during minimally invasive SI joint fusion.
The TiLink implant features proprietary Nanotex nano-surface technology and a compression-based design intended to support bone integration and joint stabilization. Pre-clinical ovine studies have demonstrated that Nanotex surface technology promotes both bone on-growth and in-growth at the implant interface, supporting enhanced stability and fusion potential.
Copy to clipboard 
